What are the potential side effects of Strattera (Atomoxetine) in a 45-year-old male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Potential Side Effects of Strattera (Atomoxetine) in a 45-Year-Old Male

In a 45-year-old male, atomoxetine commonly causes dry mouth, constipation, nausea, decreased appetite, insomnia, dizziness, sweating, urinary problems (dysuria), sexual dysfunction, and palpitations, with modest increases in heart rate and blood pressure that are generally well tolerated. 1, 2, 3

Common Side Effects in Adult Males

The side effect profile differs between adults and children, with adults experiencing a distinct pattern:

  • Gastrointestinal effects: Constipation, dry mouth, nausea, and decreased appetite are among the most frequent complaints 2, 3
  • Cardiovascular effects: Modest increases in heart rate (1-2 beats per minute) and blood pressure (1-4 mm Hg) occur but are generally clinically insignificant and well tolerated 4, 5
  • Sleep disturbances: Insomnia is reported significantly more frequently than with placebo 2, 3
  • Urogenital effects: Dysuria (difficulty urinating) and sexual dysfunction are notable concerns in adult males 1, 2
  • Other common effects: Dizziness, sweating, and palpitations occur more frequently than placebo 2, 3

Sexual Dysfunction Considerations

Sexual side effects warrant particular attention in adult males, as poor CYP2D6 metabolizers experience erectile dysfunction at rates of 21% versus 9% in extensive metabolizers. 4

  • This represents a significant quality-of-life concern that should be discussed proactively 4
  • The risk is substantially higher in poor metabolizers due to elevated plasma levels 4, 5

Serious Adverse Effects Requiring Monitoring

While less common, several serious side effects require vigilance:

  • Cardiovascular monitoring: Regular heart rate and blood pressure checks are recommended, particularly in the first 5-10% of patients who may experience potentially clinically important changes 4, 6
  • Hepatotoxicity: Extremely rare but serious liver injury can occur; discontinue immediately if jaundice or clinically significant liver dysfunction develops 4, 6
  • Urinary retention: Problems initiating or maintaining urine stream, or inability to fully empty the bladder may occur 1
  • Priapism: Rare but serious; erections lasting more than 4 hours require immediate medical attention to prevent permanent damage 1
  • Serious allergic reactions: Including trouble breathing, swelling, or hives 1

Important Clinical Considerations for Adults

The suicidal ideation black box warning applies to individuals through age 24 years, meaning your 45-year-old patient is NOT at increased risk based on the FDA analysis. 7, 4

  • Meta-analysis showed increased suicidal ideation risk in children and adolescents but NOT in adults 4
  • This is a critical distinction when counseling adult patients 4

CYP2D6 Metabolizer Status Impact

Approximately 7% of the population are poor CYP2D6 metabolizers, which significantly affects side effect profiles:

  • Poor metabolizers experience: 10-fold higher steady-state plasma concentrations, longer half-life (21.6 hours vs 5.2 hours), and significantly higher rates of adverse effects 4, 5, 8
  • Specific increased risks in poor metabolizers: Depression (7% vs 4%), syncope (3% vs 1%), dry mouth (35% vs 17%), and erectile dysfunction (21% vs 9%) 4
  • Drug interactions: SSRIs and other CYP2D6 inhibitors (like paroxetine) can convert extensive metabolizers into functional poor metabolizers, increasing side effect risk 4, 5

Tolerability and Discontinuation

  • Withdrawal rates due to adverse events in major adult trials ranged from 7.8-9.3% with atomoxetine versus 2.4-4.3% with placebo 2, 3
  • Most adverse events are mild to moderate in severity 5
  • Discontinuation is generally well tolerated with low incidence of withdrawal symptoms 5
  • Atomoxetine is not associated with QT interval prolongation 2, 3

Contraindications and Drug Interactions

  • Absolute contraindication: Concomitant use with MAOIs due to risk of serotonin syndrome 4
  • Caution with: Asthma medicines, antidepressants, blood pressure medications, and decongestants 1
  • Pregnancy considerations: Not applicable to your male patient, but atomoxetine is contraindicated in pregnancy 1

References

Guideline

Atomoxetine Mechanism and Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Atomoxetine Side Effects and Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical pharmacokinetics of atomoxetine.

Clinical pharmacokinetics, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.